Bioavailability of hop-derived iso-α-acids and reduced derivatives
2011
Cattoor, Ko | Remon, Jean-Paul | Boussery, Koen | Van Bocxlaer, Jan | Bracke, Marc | De Keukeleire, Denis | Deforce, Dieter | Heyerick, A. (Arne)
Iso-α-acids (IAA) and their reduced derivatives (dihydro-iso-α-acids (DHIAA) and tetrahydro-iso-α-acids (THIAA)) have been administered to Caco-2 cell monolayers (30, 60, and 120 μM) to investigate epithelial transport, in both absorptive and secretive directions. In addition, 25 mg kg⁻¹ IAA, DHIAA, and THIAA were applied to New Zealand white rabbits (±3–3.5 kg) in a single intravenous and oral dose. The most important pharmacokinetic parameters (Cₘₐₓ, tₘₐₓ, half life, clearance, and AUC₀₋∞) and the absolute bioavailability were determined for each class of hop acid. The results from the in vitro Caco-2 study of IAA, DHIAA, and THIAA, showed a higher membrane permeability for IAA and THIAA, both in absorptive (PₐₚₚAB range 1.6–5.6 × 10⁻⁶ cm s⁻¹) and secretive directions (PₐₚₚBA range 5.7–16.3 × 10⁻⁶ cm s⁻¹), when compared to DHIAA. Factors limiting transport of DHIAA could include phase II metabolism. After oral and i.v. dosing to New Zealand white rabbits, the absolute bioavailability for IAA was determined to be 13.0%. The reduced derivatives reached higher bioavailabilities with 28.0% for DHIAA and 23.0% for THIAA. The area under curve AUC₀₋∞ upon oral gavage for DHIAA and THIAA was 70.7 ± 48.4 μg h ml⁻¹ and 57.4 ± 9.0 μg h ml⁻¹, respectively, while that for IAA was 10.6 ± 5.3 μg h ml⁻¹. Phase I metabolism was indicated as the main factor limiting the bioavailability of IAA. Bioavailability of DHIAA is mostly influenced by phase-II metabolism as shown by enzymatic hydrolysis of plasma samples upon administration of DHIAA.
Afficher plus [+] Moins [-]Mots clés AGROVOC
Informations bibliographiques
Cette notice bibliographique a été fournie par National Agricultural Library
Découvrez la collection de ce fournisseur de données dans AGRIS